Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Ketamine, SGB and Combination Treatment for TBI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Northwestern University is evaluating ketamine with stellate ganglion block and a combination approach for traumatic brain injury,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Northwestern University | Conditions: Posttraumatic Headache, Posttraumatic Stress Disorder | Phase 2 | Status: RECRUITING